FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986038576> ?p ?o ?g. }

• W1986038576 endingPage "651" @default.
• W1986038576 startingPage "644" @default.
• W1986038576 abstract "OBJECTIVE We have developed a new antihyperglycemic agent (teglicar) through the selective and reversible inhibition of the liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1). RESEARCH DESIGN AND METHODS Glucose production was investigated in isolated hepatocytes and during pancreatic clamps in healthy rats. Chronic treatments on C57BL/6J, db/db, high-fat fed mice, and rats were performed to understand glucose metabolism and insulin sensitivity. RESULTS In isolated hepatocytes, teglicar concentration dependently reduced ketone bodies and glucose production up to 72 and 50%, respectively. In rats, teglicar reduced the endogenous glucose production (−62%) without affecting peripheral glucose utilization. Heart 2-[3H]deoxyglucose uptake in mice was also not affected, confirming in vivo the drug selectivity toward L-CPT1. Chronic treatment in db/db mice (50 mg/kg/bid; 45 days) reduced postabsorptive glycemia (−38%), water consumption (−31%), and fructosamine (−30%). Such antidiabetic activity was associated with an improved insulin sensitivity assessed by the insulin tolerance test. A significant 50% increase in hepatic triglyceride content (HTGC) was found, although plasma alanineaminotransferase was not altered. In addition, long-term teglicar administration to high-fat fed C57BL/6J mice normalized glycemia (−19%) and insulinemia (−53%). Long-term teglicar administration (30 days, 80 mg/kg) in healthy overnight-fasted rats slightly reduced basal glycemia (−20%, ns), reduced basal insulin levels by 60%, doubled triglycerides, and increased free-fatty acids (+53%). HTGC was markedly increased, but liver and peripheral insulin sensitivity assessed by hyperinsulinemiceuglycemic clamp were not affected. CONCLUSIONS Teglicar, in vitro and in animal models, reduces gluconeogenesis and improves glucose homeostasis, refreshing the interest in selective and reversible L-CPT1 inhibition as a potential antihyperglycemic approach." @default.
• W1986038576 created "2016-06-24" @default.
• W1986038576 creator A5002424668 @default.
• W1986038576 creator A5007543034 @default.
• W1986038576 creator A5028821822 @default.
• W1986038576 creator A5039515898 @default.
• W1986038576 creator A5049912464 @default.
• W1986038576 creator A5056233734 @default.
• W1986038576 creator A5059685674 @default.
• W1986038576 date "2011-01-21" @default.
• W1986038576 modified "2023-10-11" @default.
• W1986038576 title "Selective Reversible Inhibition of Liver Carnitine Palmitoyl-Transferase 1 by Teglicar Reduces Gluconeogenesis and Improves Glucose Homeostasis" @default.
• W1986038576 cites W1980358102 @default.
• W1986038576 cites W1993045506 @default.
• W1986038576 cites W1995483958 @default.
• W1986038576 cites W1997585363 @default.
• W1986038576 cites W2010126391 @default.
• W1986038576 cites W2012898950 @default.
• W1986038576 cites W2015370901 @default.
• W1986038576 cites W2016850962 @default.
• W1986038576 cites W2031545586 @default.
• W1986038576 cites W2031846075 @default.
• W1986038576 cites W2040499509 @default.
• W1986038576 cites W2042764090 @default.
• W1986038576 cites W2047399305 @default.
• W1986038576 cites W2049454720 @default.
• W1986038576 cites W2074390251 @default.
• W1986038576 cites W2079195930 @default.
• W1986038576 cites W2092340120 @default.
• W1986038576 cites W2094507651 @default.
• W1986038576 cites W2098545392 @default.
• W1986038576 cites W2105897677 @default.
• W1986038576 cites W2108916652 @default.
• W1986038576 cites W2112327050 @default.
• W1986038576 cites W2124978951 @default.
• W1986038576 cites W2137271883 @default.
• W1986038576 cites W2146877877 @default.
• W1986038576 cites W2148501195 @default.
• W1986038576 cites W2151098562 @default.
• W1986038576 cites W2157398808 @default.
• W1986038576 cites W2166322988 @default.
• W1986038576 cites W2167009109 @default.
• W1986038576 cites W2169814087 @default.
• W1986038576 cites W2171699473 @default.
• W1986038576 cites W2264108710 @default.
• W1986038576 cites W2282684438 @default.
• W1986038576 cites W62982708 @default.
• W1986038576 cites W78381853 @default.
• W1986038576 doi "https://doi.org/10.2337/db10-0346" @default.
• W1986038576 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3028366" @default.
• W1986038576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21270274" @default.
• W1986038576 hasPublicationYear "2011" @default.
• W1986038576 type Work @default.
• W1986038576 sameAs 1986038576 @default.
• W1986038576 citedByCount "65" @default.
• W1986038576 countsByYear W19860385762012 @default.
• W1986038576 countsByYear W19860385762013 @default.
• W1986038576 countsByYear W19860385762014 @default.
• W1986038576 countsByYear W19860385762015 @default.
• W1986038576 countsByYear W19860385762016 @default.
• W1986038576 countsByYear W19860385762017 @default.
• W1986038576 countsByYear W19860385762018 @default.
• W1986038576 countsByYear W19860385762019 @default.
• W1986038576 countsByYear W19860385762020 @default.
• W1986038576 countsByYear W19860385762021 @default.
• W1986038576 countsByYear W19860385762022 @default.
• W1986038576 countsByYear W19860385762023 @default.
• W1986038576 crossrefType "journal-article" @default.
• W1986038576 hasAuthorship W1986038576A5002424668 @default.
• W1986038576 hasAuthorship W1986038576A5007543034 @default.
• W1986038576 hasAuthorship W1986038576A5028821822 @default.
• W1986038576 hasAuthorship W1986038576A5039515898 @default.
• W1986038576 hasAuthorship W1986038576A5049912464 @default.
• W1986038576 hasAuthorship W1986038576A5056233734 @default.
• W1986038576 hasAuthorship W1986038576A5059685674 @default.
• W1986038576 hasBestOaLocation W19860385761 @default.
• W1986038576 hasConcept C126322002 @default.
• W1986038576 hasConcept C134018914 @default.
• W1986038576 hasConcept C17093226 @default.
• W1986038576 hasConcept C185592680 @default.
• W1986038576 hasConcept C20904676 @default.
• W1986038576 hasConcept C2777391703 @default.
• W1986038576 hasConcept C2777866211 @default.
• W1986038576 hasConcept C2778024521 @default.
• W1986038576 hasConcept C2778163477 @default.
• W1986038576 hasConcept C2778435403 @default.
• W1986038576 hasConcept C2778808658 @default.
• W1986038576 hasConcept C2778913445 @default.
• W1986038576 hasConcept C2779306644 @default.
• W1986038576 hasConcept C2780352109 @default.
• W1986038576 hasConcept C2781357877 @default.
• W1986038576 hasConcept C3018667095 @default.
• W1986038576 hasConcept C31532488 @default.
• W1986038576 hasConcept C62231903 @default.
• W1986038576 hasConcept C71924100 @default.
• W1986038576 hasConcept C86803240 @default.
• W1986038576 hasConceptScore W1986038576C126322002 @default.
• W1986038576 hasConceptScore W1986038576C134018914 @default.

• next